Abstract: Optimizing viewing assets, such as three-dimensional (3D) virtual objects for mixed reality (MR), virtual reality (VR), or augmented reality (AR) environment visualization may involve obtaining a viewing asset, generating a decimation request for the obtained viewing asset, responsive to generating the decimation request, receiving a set of decimation files, based at least on the set of decimation files, generating a plurality of selectable options, receiving a user selection of an option, and outputting the selected option as a converted viewing asset. Disclosed examples may also include specifying a maximum file size, a minimum polygon count, a maximum polygon count, and a minimum number of renderable viewing assets on a target display platform. Disclosed examples may operate automatically, and may permit tailoring of a decimation recipe.

Abstract: Optimizing viewing assets, such as three-dimensional (3D) virtual objects for mixed reality (MR), virtual reality (VR), or augmented reality (AR) environment visualization may involve obtaining a viewing asset, generating a decimation request for the obtained viewing asset, responsive to generating the decimation request, receiving a set of decimation files, based at least on the set of decimation files, generating a plurality of selectable options, receiving a user selection of an option, and outputting the selected option as a converted viewing asset. Disclosed examples may also include specifying a maximum file size, a minimum polygon count, a maximum polygon count, and a minimum number of renderable viewing assets on a target display platform. Disclosed examples may operate automatically, and may permit tailoring of a decimation recipe.

Abstract: Methods for treating obesity, reducing total weight and reducing body fat mass by administering a composition comprising dihydroquercetins and root-derived aralosides A, B, C and D is disclosed.

Abstract: The present invention encompasses pharmaceutical compositions for the treatment of obesity. These compositions comprise dihydroquercetins (dihydroquercetin 3-rhamnoside and its aglycon dihydroquercetin) and the triterpene saponins known as aralosides or elatosides. The compositions of the present invention effectively promote total weight loss and body fat mass loss. Therefore, the present invention is also directed to methods for treating obesity, reducing total weight, and reducing body fat mass by administering the compositions of the invention. The invention also embraces methods for disrupting the perilipin shell of lipid droplets and stimulating the activity of hormone-sensitive lipase.